The thyroid and fibrinolysis.
作者信息
Bennett N B, Ogston C M, McAndrew G M
出版信息
Br Med J. 1967 Oct 28;4(5572):147-8. doi: 10.1136/bmj.4.5572.147.
Abstract
摘要
相似文献
1
The thyroid and fibrinolysis.甲状腺与纤维蛋白溶解
Br Med J. 1967 Oct 28;4(5572):147-8. doi: 10.1136/bmj.4.5572.147.
2
FIBRINOLYTIC ACTIVITY AND THYROID FUNCTION.纤溶活性与甲状腺功能。
Br Med J. 1965 Mar 13;1(5436):686-8. doi: 10.1136/bmj.1.5436.686.
3
The serum creatine phosphokinase activity and the Achilles reflex in hyperthyroidism and hypothyroidism.甲状腺功能亢进和减退时的血清肌酸磷酸激酶活性及跟腱反射
Acta Med Scand. 1966 Apr;179(4):433-40. doi: 10.1111/j.0954-6820.1966.tb05480.x.
4
[The value of serum creatine kinase activity determinations as a thyroid function test].
Rev Fr Etud Clin Biol. 1968 Nov;13(9):905-9.
5
[Serum creatine kinase in thyroid disorders].[甲状腺疾病中的血清肌酸激酶]
Ann Endocrinol (Paris). 1971 Jan-Feb;32(1):142-56.
6
Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.原发性甲状腺功能减退症患者的血栓酶激活的纤溶抑制物（TAFI）抗原和活性测定。
Clin Appl Thromb Hemost. 2010 Oct;16(5):568-73. doi: 10.1177/1076029609350890. Epub 2009 Dec 2.
7
Quantitative studies of iodine metabolism after long-term treatment of thyrotoxicosis with antithyroid drugs.抗甲状腺药物长期治疗甲状腺毒症后碘代谢的定量研究。
J Clin Endocrinol Metab. 1966 Apr;26(4):397-401. doi: 10.1210/jcem-26-4-397.
8
Laboratory tests for evaluating thyroid therapy.评估甲状腺治疗的实验室检查。
Am Fam Physician. 1982 Sep;26(3):183-8.
9
[Current status of thyroid function diagnosis].[甲状腺功能诊断的现状]
Lakartidningen. 1976 May 19;73(21):2014-6.
10
[Effect of stress on concentration of blood glycoproteins in rats with different functional changes in the thyroid gland].[应激对甲状腺功能发生不同改变的大鼠血液中糖蛋白浓度的影响]
Vopr Med Khim. 1982 May-Jun;28(3):89-94.
引用本文的文献
1
Hemostasis in Overt and Subclinical Hyperthyroidism.显性和亚临床甲状腺功能亢进症中的止血作用。
Int J Endocrinol Metab. 2017 Apr 23;15(3):e44157. doi: 10.5812/ijem.44157. eCollection 2017 Jul.
2
Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.甲状腺功能减退症和自身免疫性甲状腺疾病中的止血作用。
Int J Endocrinol Metab. 2017 Mar 9;15(2):e42649. doi: 10.5812/ijem.42649. eCollection 2017 Apr.
3
Fibinolysis in colonic disease.结肠疾病中的纤维蛋白溶解
Gut. 1970 Jul;11(7):588-91. doi: 10.1136/gut.11.7.588.
4
Haemostasis in hypothyroidism.甲状腺功能减退症中的止血
Postgrad Med J. 1990 Apr;66(774):280-4. doi: 10.1136/pgmj.66.774.280.
本文引用的文献
1
Partial purification and properties of a proteolytic enzyme of human serum.人血清中一种蛋白水解酶的部分纯化及性质
J Biol Chem. 1949 Nov;181(1):431-48.
2
A new method for the determination of fibrinogen in small samples of plasma.一种测定少量血浆样本中纤维蛋白原的新方法。
J Lab Clin Med. 1951 Feb;37(2):316-20.
3
FIBRINOLYTIC ACTIVITY AND THYROID FUNCTION.纤溶活性与甲状腺功能。
Br Med J. 1965 Mar 13;1(5436):686-8. doi: 10.1136/bmj.1.5436.686.
4
ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.肝硬化患者纤溶酶原-纤溶酶系统活性异常（纤维蛋白溶解）：其原因及后果
J Clin Invest. 1964 Apr;43(4):681-95. doi: 10.1172/JCI104953.
5
The mechanism of clot dissolution by plasmin.纤溶酶溶解血栓的机制。
J Clin Invest. 1959 Jul;38(7):1086-95. doi: 10.1172/JCI103885.
6
Studies on enhanced fibrinolytic activity in man.关于人类纤维蛋白溶解活性增强的研究。
J Clin Invest. 1959 May;38(5):810-22. doi: 10.1172/JCI103863.
7
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease.健康人群与缺血性心脏病患者的血浆纤维蛋白原和纤溶酶原水平
J Clin Pathol. 1966 Jul;19(4):352-6. doi: 10.1136/jcp.19.4.352.
8
A method for the quantitative assay of inhibitor of plasminogen activation in human serum.一种定量测定人血清中纤溶酶原激活抑制剂的方法。
Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):12-22.
Zotero 插件